Showing 67,821 - 67,840 results of 106,674 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.17s Refine Results
  1. 67821

    The sera obtained from the patients with t-CIDP, MADSAM and DADS disrupted the BNB. by Fumitaka Shimizu (545145)

    Published 2014
    “…<p>(A) – (D) Effects of the sera obtained from patients with three different phenotypes of chronic inflammatory demyelinating polyneuropathy (CIDP) on the protein levels of claudin-5 and occludin in the FH-BNBs, as determined using a Western blot analysis. …”
  2. 67822

    Image_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  3. 67823

    Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort by Barbara Bartmeyer (51157)

    Published 2010
    “…NRTI resistance was predominant (7.5%) but decreased significantly over time (CI<sub>Wilson</sub>: 6.2–9.1, p<sub> for trend</sub> = 0.02). …”
  4. 67824

    Image_2_Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats.TIF by Jingwei Zheng (521396)

    Published 2018
    “…Hyperglycemia was induced by intraperitoneal injection with streptozotocin. Honokiol (HKL, a pharmacological agonist of sirt3) was injected intraperitoneally at doses of 2.5, 5, or 10 mg/kg. …”
  5. 67825

    Image_1_Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats.TIF by Jingwei Zheng (521396)

    Published 2018
    “…Hyperglycemia was induced by intraperitoneal injection with streptozotocin. Honokiol (HKL, a pharmacological agonist of sirt3) was injected intraperitoneally at doses of 2.5, 5, or 10 mg/kg. …”
  6. 67826

    Image_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  7. 67827

    Table_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  8. 67828

    Table_3_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  9. 67829

    Image_3_Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats.TIF by Jingwei Zheng (521396)

    Published 2018
    “…Hyperglycemia was induced by intraperitoneal injection with streptozotocin. Honokiol (HKL, a pharmacological agonist of sirt3) was injected intraperitoneally at doses of 2.5, 5, or 10 mg/kg. …”
  10. 67830

    Data_Sheet_1_Cognitive training of mice attenuates age-related decline in associative learning and behavioral flexibility.docx by Dalia Attalla (18154114)

    Published 2024
    “…Spatial working memory and attention were evaluated using the trial unique non-matching to location (TUNL) and the five-choice serial reaction time task (5-CSRTT), respectively. …”
  11. 67831

    <i>lin-4</i> and its targets <i>lin-14</i> and <i>lin-28</i> are expressed reciprocally during larval development. by Katherine Olsson-Carter (244338)

    Published 2010
    “…In addition, the <i>lin-14::GFP</i> strain expressed GFP more weakly than the <i>lin-28</i> reporter during the L1, and thus a much smaller decrease in relative pixel intensity was required for complete down-regulation of the <i>lin-14::GFP</i> transgene. p-values for differences in relative pixel intensity were obtained using the two-sample t-test. …”
  12. 67832

    Table_1_Biosynthesis of LC-PUFA in Ruditapes philippinarum: Cloning and tissue distribution of Fad and Elovl, and effects of microalgae diets varied in LC-PUFA composition on their... by Kaibin Wu (9753011)

    Published 2023
    “…However, the R. philippinarum fed with Chlorella sp. exhibited a significant decrease of 18:2n-6 and 18:3n-3 but with a significant increase of their products such as 20:3n-6 and 22:5n-3, indicating that R. philippinarum had a certain capacity for LC-PUFA biosynthesis. …”
  13. 67833

    Image_4_Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats.TIF by Jingwei Zheng (521396)

    Published 2018
    “…Hyperglycemia was induced by intraperitoneal injection with streptozotocin. Honokiol (HKL, a pharmacological agonist of sirt3) was injected intraperitoneally at doses of 2.5, 5, or 10 mg/kg. …”
  14. 67834

    Table_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  15. 67835

    Resistance and tolerance: the role of nutrients on pathogen dynamics and infection outcomes in an insect host by Charlotte Miller (4410157)

    Published 2017
    “…The dose required to kill 50% of individuals in this species was several magnitudes higher than in other species and the bacteria were shown to display massive decreases in population size, in contrast to patterns of proliferation found in other host species. …”
  16. 67836

    Evolution of the index lesion over time during the study. by Oussama Mouri (573438)

    Published 2023
    “…By day 28, the mean index lesion size reduced by approximately 50% and 99% by day 100 compared with the baseline lesion.…”
  17. 67837

    SiRNA-Induced Mutation in HIV-1 Polypurine Tract Region and Its Influence on Viral Fitness by Jason W. Rausch (66803)

    Published 2015
    “…Introducing either or both mutations into the 3′PPT region or only the G(-1)A substitution in the cPPT region of NL4-3 produced infectious virus with decreased fitness relative to the wild-type virus. …”
  18. 67838

    Data_Sheet_1_Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients.docx by Pan Wang (198097)

    Published 2024
    “…The present study is an 8-week study, consisting of 4 consecutive doses of efgartigimod administered over 3 weeks (one cycle), followed by a 5-week follow-up period to assess the tolerability of efgartigimod’s therapeutic effects. …”
  19. 67839

    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity by David Pereyra (685397)

    Published 2017
    “…</p><p>Results</p><p>Patients developing postoperative liver dysfunction (LD) had a more pronounced postoperative decrease in ATIII-activity (P<0.001). …”
  20. 67840

    Data_Sheet_1_Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients.docx by Pan Wang (198097)

    Published 2024
    “…The present study is an 8-week study, consisting of 4 consecutive doses of efgartigimod administered over 3 weeks (one cycle), followed by a 5-week follow-up period to assess the tolerability of efgartigimod’s therapeutic effects. …”